Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Boosted protease inhibitor for HIV, mostly used as a second-line option. | Core of the WHO-preferred HIV treatment. |
| Body system | Antivirals | Antivirals |
| Drug class | Viral protease inhibitors | Integrase inhibitors |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | HIV infection (with other drugs) | HIV-1 treatment (with other antiretrovirals) |
| How it works | Stops HIV from maturing into infectious viruses. | Stops HIV inserting its genes into your cells' DNA. |
| Starts working | Weeks | — |
| Half-life | 5–6 hours | About 14 hours |
| Typical adult dose | 400/100 mg twice a day, or 800/200 mg once a day in some patients. | 50 mg once a day (twice a day with rifampicin or certain resistance). |
| Forms | Tablet, Oral solution | Tablet, Dispersible tablet, Combination tablets (TLD, Triumeq, Dovato) |
| Common side effects | Diarrhoea, Nausea, Raised cholesterol and triglycerides, Tiredness | Headache, Insomnia, Weight gain, Nausea |
| Serious side effects | Pancreatitis, Liver injury, QT and PR prolongation, Insulin resistance | Hypersensitivity reaction (rare), Liver injury in hepatitis co-infection, Depression (rare) |
| Don't take if | Taking simvastatin, lovastatin, rifampicin, St John's wort; Severe liver disease | — |
| Alcohol | Best to limit. Alcohol increases pancreatitis and liver risk. | — |
| Pregnancy | Generally considered safeWidely used in pregnancy within HIV regimens. | Generally considered safeAn early signal of neural tube defects shrank with more data; WHO recommends it for all, including in pregnancy. |
| Breastfeeding | Usually avoidedNot recommended where safe formula is available. | — |
| In use since | — | 2013 |
| Brand names | United States: KaletraUnited Kingdom: KaletraIndia: Lopimune, Lopinavir-ritonavir (generic) | United States: TivicayUnited Kingdom: TivicayAustralia: Tivicay |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | — |
| ATC code | J05AR10 | J05AJ03 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker